Delhi Chief Minister Rekha Gupta inaugurates a new waiting area at AIIMS
Delhi Chief Minister Rekha Gupta inaugurated the newly-constructed Dhanuka Waiting Area at the All India Institute of Medical Sciences (AIIMS), New Delhi, on Wednesday. The facility has been developed under a CSR initiative by Dhanuka Group, a leading agro-product company.CM Gupta also participated in a hawan and pooja ceremony as part of the inauguration. Speaking to the media, she said AIIMS Delhi has witnessed major improvements over the past 10 years, especially since 2014, when the hospital was in poor condition.advertisementAIIMS is the biggest hospital in the country and handles about five lakh OPD cases annually. Before 2014, the hospital was in disarray. In the last 10 years, the facilities have improved significantly. "I thank the Dhanuka Group for this much-needed waiting area,' said CM Rekha Gupta.
The Chief Minister said that many attendants accompanying patients have to sit on the roads due to the lack of proper space. The newly built waiting hall aims to provide a comfortable resting space for these visitors.'This is a big relief for families. CSR efforts like these not only improve services but also enhance the beauty of our city,' she added. TREE PLANTATION AT AIIMS UNDER 'EK PED MAA KE NAAM'Chief Minister Gupta also planted a tree on the AIIMS campus as part of the 'Ek Ped Maa Ke Naam' campaign, a green initiative to promote environmental awareness.advertisementCM Rekha Gupta stated that significant infrastructure projects worth Rs 35,000 crore under the National Highways Authority of India (NHAI) are currently under construction in the national capital during a press conference at the Ministry of Road Transport and Highways. She also mentioned that the earlier projects with a value of Rs 64,000 crore have been completed, as well as another set of projects valued at Rs 24,000 crore, which will begin soon."I thank the Central Government and Union Minister Nitin Gadkari for developing roads and infrastructure in Delhi with the support of these enormous expenses."The Chief Minister also stated that the government stands by its commitment to fixing healthcare and transport infrastructure with the added figures for people's convenience.With inputs from ANI
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
Tejashwi raises concerns over law & order, health infra
Patna: Leader of opposition in the state assembly, Tejashwi Prasad Yadav , on Friday launched an attack on the NDA in the state, alleging that "a tired CM and retired officials" were governing the state. Talking to reporters here on Friday, Tejashwi criticised CM Nitish Kumar, stating that the latter is "unfit" to rule the state. "The people of the state are feeling insecure and warned them to be careful," he said. At the same time, he also issued a warning to the people, advising them to be alert while in Bihar. "Be alert, be cautious, be careful in Bihar! Protect your life and property yourself because criminals left 'unshackled' in the past 20 years can go to any extent," Tejashwi posted on X on Friday, claiming "the information has been issued in public interest." He also criticised the state's health infrastructure, particularly the conditions at AIIMS-Patna and PMCH. "There is no bed available for genuine patients there. When I went to AIIMS, the common patients and their attendants surrounded me, crying, 'Beds dilwa dijiye (please arrange beds for us)." "If you go to another hospital, there is no action taken against the corrupt officials. Now also, you can see how a retired health official is being protected. My question is why a retired official was granted an extension as soon as our govt collapsed? Is there no one else eligible to manage the PMCH?" he asked. Get the latest lifestyle updates on Times of India, along with Eid wishes , messages , and quotes !
Time of India
2 hours ago
- Time of India
Poinguinim boar attack victim compensated
Canacona: The forest department paid a compensation of Rs 85,000 to Jayanti Velip, who developed deformities from a wild boar attack in Jan. The compensation papers were prepared by the assistant conservator of forests (South) Harsh Phadte and range forest officer, Canacona, Anant Velip, under the supervision of the deputy conservator of forests (South), Satish Kumar Reddy. Velip was working in a paddy field at Velwada, Poinguinim when a wild boar attacked her from behind. She fought with the boar and suffered injuries, resulting in 82% disability to her thumb and ear, she told TOI . After the attack, she was hospitalised for over two months and is now unable to use her right thumb or hear properly with her one ear. Get the latest lifestyle updates on Times of India, along with Eid wishes , messages , and quotes !
&w=3840&q=100)
Business Standard
3 hours ago
- Business Standard
Indian pharma market grows 7.2% in May led by chronic therapies
Indian pharma market grew 7.2% in May with strong performance in chronic therapies such as cardiac and anti-infectives, along with gains from price hikes and new launches Sanket Koul New Delhi The Indian Pharma Market (IPM) grew 7.2 per cent in May this year with almost all major therapies showing positive growth, according to market research firm Pharmarack. Data suggest that big chronic therapies such as cardiac and anti-infectives, which account for nearly 25 per cent of the overall domestic market, recorded value growth of 11.7 per cent and 7.6 per cent, respectively. On the other hand, several smaller supergroups such as urology and antineoplastics, which made up 2 per cent each of the IPM's sales value for the month, also recorded double-digit growth in May at 12.3 per cent and 11.7 per cent, said Sheetal Sapale, vice-president, commercial, Pharmarack. Data suggest that the overall value growth for the IPM in May was driven by price growth and new introductions. The IPM also reported a minuscule 0.4 per cent unit growth during the month, with the chronic segments such as antidiabetics (6.1 per cent) and cardiac (4.8 per cent) performing better than the overall market figure. Experts believe that the antidiabetic segment saw a 6.1 per cent rise in volume in May due to a key drug, empagliflozin, going off-patent, as companies launched several plain and combination medications in the segment. Growth in the moving annual turnover (MAT) for the IPM between June 2024 and May 2025 stood at 8.1 per cent, leading to a total turnover of over Rs 2.29 trillion, while volumes in the domestic market grew by 1.1 per cent. The MAT of leading therapy areas such as cardiac, gastrointestinal and anti-infectives, which constitute around 38 per cent of the pharmaceutical market, showed robust volume growth at 10.4 per cent, 9.5 per cent and 6.5 per cent, respectively. While the top 20 brands in the IPM registered modest monthly value growth in the domestic market during the month, Sun Pharma and Dr Reddy's posted significant monthly value growth at 11.2 per cent each. They were followed by Torrent Pharma and Ipca Laboratories at 10.8 per cent, and Alkem Laboratories at 10.3 per cent monthly value growth. According to Pharmarack data, GlaxoSmithKline's (GSK) antibiotic medication Augmentin and USV's anti-diabetic drug Glycomet GP continued to be the top-selling medicine brands at the MAT level, with sales worth Rs 819 crore and Rs 810 crore, respectively.
